Inotuzumab ozogamicin Intravenous and Insulin degludec Subcutaneous
Determining the interaction of Inotuzumab ozogamicin Intravenous and Insulin degludec Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab ozogamicin, Inotuzumab Ozogamicin
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotuzumab ozogamicin Intravenous-Insulin detemir
- Inotuzumab ozogamicin Intravenous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Inotuzumab ozogamicin Intravenous-Insulin Detemir (Vials)
- Inotuzumab ozogamicin Intravenous-Insulin detemir Subcutaneous
- Inotuzumab ozogamicin Intravenous-Insulin glargine
- Inotuzumab ozogamicin Intravenous-Insulin Glargine (U-100) Cartridge Systems and Pens
- Insulin degludec Subcutaneous-Inova
- Insulin degludec Subcutaneous-Inova 4/1 topical
- Insulin degludec Subcutaneous-Inova 8/2 topical
- Insulin degludec Subcutaneous-Inova ACT
- Insulin degludec Subcutaneous-Inrebic
- Insulin degludec Subcutaneous-Inspra